Guoqiang Shao

1.2k total citations
71 papers, 888 citations indexed

About

Guoqiang Shao is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Biomedical Engineering. According to data from OpenAlex, Guoqiang Shao has authored 71 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 23 papers in Oncology and 21 papers in Biomedical Engineering. Recurrent topics in Guoqiang Shao's work include Radiopharmaceutical Chemistry and Applications (17 papers), Nanoplatforms for cancer theranostics (16 papers) and Prostate Cancer Treatment and Research (9 papers). Guoqiang Shao is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (17 papers), Nanoplatforms for cancer theranostics (16 papers) and Prostate Cancer Treatment and Research (9 papers). Guoqiang Shao collaborates with scholars based in China, United States and Namibia. Guoqiang Shao's co-authors include Yang Zhou, Shuang Liu, Shundong Ji, Feng Wang, Xiangdong He, Shuang Liu, Guping Tang, Jianwei Wang, Wenyu Wu and Hongzhen Bai and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and ACS Nano.

In The Last Decade

Guoqiang Shao

66 papers receiving 879 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guoqiang Shao China 18 254 248 234 206 182 71 888
Yesen Li China 15 215 0.8× 230 0.9× 307 1.3× 171 0.8× 111 0.6× 45 766
Zheng Han China 16 153 0.6× 151 0.6× 376 1.6× 206 1.0× 92 0.5× 50 947
Hsin-Ell Wang Taiwan 23 368 1.4× 464 1.9× 506 2.2× 211 1.0× 176 1.0× 69 1.4k
Lingyi Sun China 12 106 0.4× 172 0.7× 258 1.1× 228 1.1× 108 0.6× 34 659
Rubi Mahato United States 5 195 0.8× 203 0.8× 418 1.8× 246 1.2× 76 0.4× 5 795
Chiun-Wei Huang United States 12 168 0.7× 224 0.9× 172 0.7× 162 0.8× 69 0.4× 14 559
Jesper Tranekjær Jørgensen Denmark 19 270 1.1× 552 2.2× 496 2.1× 224 1.1× 178 1.0× 50 1.3k
Anna Massaguer Spain 26 147 0.6× 97 0.4× 488 2.1× 463 2.2× 124 0.7× 58 1.5k
Fangyuan Chen China 18 157 0.6× 69 0.3× 444 1.9× 149 0.7× 117 0.6× 72 1.2k
Jungshan Chang Taiwan 19 200 0.8× 56 0.2× 386 1.6× 223 1.1× 91 0.5× 50 909

Countries citing papers authored by Guoqiang Shao

Since Specialization
Citations

This map shows the geographic impact of Guoqiang Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoqiang Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoqiang Shao more than expected).

Fields of papers citing papers by Guoqiang Shao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoqiang Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoqiang Shao. The network helps show where Guoqiang Shao may publish in the future.

Co-authorship network of co-authors of Guoqiang Shao

This figure shows the co-authorship network connecting the top 25 collaborators of Guoqiang Shao. A scholar is included among the top collaborators of Guoqiang Shao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoqiang Shao. Guoqiang Shao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiaoyuan, Tiantian Guo, Lele Zhang, et al.. (2025). Fully automated volumetric assessment of tumor burden using artificial intelligence on 68Ga-PSMA-11 PET predicts survival after 177Lu-PSMA therapy in metastatic Castration-resistant prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 53(3). 1913–1926.
2.
3.
Yao, Jingwen, Guoqiang Shao, Donatello Telesca, et al.. (2025). Interplay Between Sex and Cytosine‐Adenine‐Guanine‐Age Product Score in Huntington's Disease: Clinical and Neuroimaging Perspectives. Movement Disorders. 41(2). 489–499.
4.
Huang, Jinxin, Rui Yang, Huan Long, et al.. (2024). Dual-drug loaded chondroitin sulfate embolization beads enhance TACE therapy for HCC by integrating embolization, chemotherapy, and anti-angiogenesis. Materials Today Bio. 30. 101419–101419. 5 indexed citations
5.
Zhang, Lingtao, Guoqiang Shao, Yamei Jin, Na Yang, & Xueming Xu. (2024). Applying layer-by-layer deposition to enhance stability and rheological behavior of emulsions: A review. Food Hydrocolloids. 158. 110537–110537. 5 indexed citations
6.
Tang, Chao, Guo‐Qing Zhu, Li Liu, et al.. (2024). HNF4α ubiquitination mediated by Peli1 impairs FAO and accelerates pressure overload-induced myocardial hypertrophy. Cell Death and Disease. 15(2). 135–135. 4 indexed citations
7.
Wang, Qian, Guoqiang Shao, Xiaoyi Zhao, et al.. (2024). Dysregulated fibrinolysis and plasmin activation promote the pathogenesis of osteoarthritis. JCI Insight. 9(8). 6 indexed citations
8.
9.
Shao, Guoqiang, Huang Zhang, Dan Xu, et al.. (2023). Insights into starch-based gels: Selection, fabrication, and application. International Journal of Biological Macromolecules. 258(Pt 2). 128864–128864. 17 indexed citations
10.
Yu, Fei, Pengjun Zhang, Guoqiang Shao, et al.. (2022). Detection of Bone Metastases by 68Ga‐DOTA‐SSAs and 18F‐FDG PET/CT: A Two‐Center Head‐to‐Head Study of Gastroenteropancreatic Neuroendocrine Neoplasms. Contrast Media & Molecular Imaging. 2022(1). 1750132–1750132. 6 indexed citations
11.
Bai, Hongzhen, Jianwei Wang, Chi Uyen Phan, et al.. (2021). Cyclodextrin-based host-guest complexes loaded with regorafenib for colorectal cancer treatment. Nature Communications. 12(1). 759–759. 94 indexed citations
12.
Xiao, Man, et al.. (2021). Research Trends, Hot Spots, and Prospects for Traditional Chinese Medicine in the Field of Ischemia-Reperfusion Injury. Evidence-based Complementary and Alternative Medicine. 2021. 1–13. 3 indexed citations
13.
Shao, Guoqiang, Yuebing Wang, Liu Xianzhong, et al.. (2018). Investigation of Newly Prepared Biodegradable 32P-chromic Phosphate-polylactide-co-glycolide Seeds and Their Therapeutic Response Evaluation for Glioma Brachytherapy. Contrast Media & Molecular Imaging. 2018. 1–11. 2 indexed citations
14.
Shao, Guoqiang, et al.. (2017). Incidental finding of 131 I uptake in mesenteric cystic lymphangioma on post-therapy 131 I SPECT/CT imaging. Revista Española de Medicina Nuclear e Imagen Molecular. 36(4). 267–268. 1 indexed citations
15.
Qu, Wei, Fan Qiu, Yan Li, et al.. (2014). 99m Tc-3P-RGD 2 Micro-Single-Photon Emission Computed Tomography/Computed Tomography Provides a Rational Basis for Integrin α v β 3 -Targeted Therapy. Cancer Biotherapy and Radiopharmaceuticals. 29(9). 351–358. 5 indexed citations
16.
Zhao, Jun, et al.. (2013). Preliminary Study of the Biodegradation and the Correlation Between In Vitro and In Vivo Release of 32 P-Chromic Phosphate-Poly(L-lactide) Seeds. Cancer Biotherapy and Radiopharmaceuticals. 28(10). 703–708. 1 indexed citations
17.
Shao, Guoqiang. (2012). Design of Practice Course Based on Enterprise Requirements. 1 indexed citations
18.
19.
Wang, Zizheng, et al.. (2012). 32 P-Chromic Phosphate–Poly( l -Lactide) Seeds of Sustained Release and Their Brachytherapy for Prostate Cancer with Lymphatic Metastasis. Cancer Biotherapy and Radiopharmaceuticals. 27(7). 446–451. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yesen Li Breakdown of academic impact, for papers by Zheng Han Breakdown of academic impact, for papers by Hsin-Ell Wang Breakdown of academic impact, for papers by Lingyi Sun Breakdown of academic impact, for papers by Rubi Mahato Breakdown of academic impact, for papers by Chiun-Wei Huang Breakdown of academic impact, for papers by Jesper Tranekjær Jørgensen Breakdown of academic impact, for papers by Anna Massaguer Breakdown of academic impact, for papers by Fangyuan Chen Breakdown of academic impact, for papers by Jungshan Chang
Rankless by CCL
2026